Broken String Biosciences is developing a platform of novel sequencing tools to assess genome stability and to unlock the next generation.
Broken String Biosciences has raised $15.0M in total funding. The most recent round was Series A. The last funding was announced in September 2023.
Broken String Biosciences's investors include Mérieux Equity Partners, Tencent, Illumina Ventures, DvH Ventures, HERAN Partners.
Broken String Biosciences is headquartered in Cambridge, United Kingdom.
Broken String Biosciences is developing a platform of novel sequencing tools to assess genome stability and to unlock the next generation.
Broken String Biosciences is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Broken String Biosciences — Funding & Investors." VCBacked, September 18, 2023, https://www.vcbacked.co/company/broken-string-biosciences. Accessed July 19, 2026.
VCBacked. (2023). Broken String Biosciences — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/broken-string-biosciences
{{cite web |title=Broken String Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/broken-string-biosciences |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated